King-Jones Heidy Insider Trades & Stock Holdings

Chief Legal Officer and Corporate Secretary · Spyre Therapeutics, Inc. · Latest filing Oct 1, 2026

King-Jones Heidy, Chief Legal Officer and Corporate Secretary at Spyre Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.63M), net -$2.63M. Latest filing: disposed of 28.93K shares of $SYRE on Oct 1, 2026 at $91.03.

Trades on file

1

Open-market bought

$0

Open-market sold

$2.63M

Net open-market

-$2.63M

Latest filing

Oct 1, 2026

All insider trades by King-Jones Heidy

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$SYRE	Sell (Open-market sale) 10b5-1	28.93K	$91.03	$2.63M			-11.2%			Chief Legal Officer and Corporate Secretary		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks King-Jones Heidy traded

• $SYRE

Frequently asked questions

Has King-Jones Heidy been buying or selling stock?

King-Jones Heidy has 0 open-market purchases and 1 open-market sale on file, net -$2.63M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was King-Jones Heidy's latest insider trade?

disposed of 28.93K shares of $SYRE on Oct 1, 2026 at $91.03.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.